Evidence map›Paper›PMID 36672636›Full record

ArticleBiomedicines2023

Therapy Defining at Initial Diagnosis of Primary Brain Tumor-The Role of

Dávid Gergő Nagy, Imre Fedorcsák, Attila György Bagó, Georgina Gáti, János Martos, Péter Szabó, Hajnalka Rajnai, István Kenessey, Katalin Borbély

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Recent developments in translational imaging of in vivo gene therapy outcomes.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Dávid Gergő NagyNational Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.
Imre FedorcsákNational Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.
Attila György BagóNational Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.
Georgina GátiNational Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.
János MartosNational Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.
Péter SzabóScanomed Ltd., 1145 Budapest, Hungary.
Hajnalka RajnaiDepartment of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0003-0934-5366
István KenesseyNational Cancer Registry, National Institute of Oncology, 1122 Budapest, Hungary.ORCID 0000-0002-6963-8489
Katalin BorbélyPET/CT Outpatient Department, National Institute of Oncology, 1122 Budapest, Hungary.ORCID 0000-0002-1675-4128
Semmelweis University · HUNational Institute of Oncology · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary malignant brain tumors are heterogeneous and infrequent neoplasms. Their classification, therapeutic regimen and prognosis have undergone significant development requiring the innovation of an imaging diagnostic. The performance of enhanced magnetic resonance imaging depends on blood-brain barrier function. Several studies have demonstrated the advantages of static and dynamic amino acid PET/CT providing accurate metabolic status in the neurooncological setting. The aim of our single-center retrospective study was to test the primary diagnostic role of amino acid PET/CT compared to enhanced MRI. Emphasis was placed on cases prior to intervention, therefore, a certain natural bias was inevitable. In our analysis for newly found brain tumors

Indexed as

18F-FET PET/CTamino acid tracersdrug treatmentglioblastomaMRIneurological disordernon enhancing tumorsperfusion weighted MRIprimary malignant brain tumors

Identifiers

PMID36672636
PMCPMC9855996
OpenAlexW4313583533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.